BRIEF published on 11/13/2025 at 18:02, 1 month 1 day ago Heights Capital Management crosses thresholds Convertible Bonds Crossing Thresholds Shares And Voting Rights GenSight Biologics Heights Capital
BRIEF published on 11/13/2025 at 18:02, 1 month 1 day ago Franchissement de seuils par Heights Capital Management Obligations Convertibles Franchissement De Seuils GenSight Biologics Actions Et Droits De Vote Heights Capital
PRESS RELEASE published on 11/13/2025 at 17:57, 1 month 1 day ago Franchissement de seuils Déclaration de franchissement de seuils par Heights Capital Management pour le compte de CVI Investments, Inc. concernant GENSIGHT BIOLOGICS S.A. sur Euronext Paris Euronext Paris Franchissement De Seuils GENSIGHT BIOLOGICS SA Heights Capital Management CVI Investments Inc.
BRIEF published on 10/30/2025 at 07:35, 1 month 16 days ago GenSight Biologics: Green light for compassionate treatment in the United States FDA GenSight Biologics NOHL Compassionate Access GS010/LUMEVOQ®
BRIEF published on 10/30/2025 at 07:35, 1 month 16 days ago GenSight Biologics : Feu vert pour un traitement compassionnel aux États-Unis FDA GenSight Biologics NOHL Accès Compassionnel GS010/LUMEVOQ®
PRESS RELEASE published on 10/30/2025 at 07:30, 1 month 16 days ago Informations privilégiées / Autres communiqués GenSight Biologics a obtenu les autorisations réglementaires pour un traitement compassionnel aux États-Unis avec GS010/LUMEVOQ, visant la Neuropathie Optique Héréditaire de Leber FDA GenSight Biologics Neuropathie Optique Héréditaire De Leber GS010/LUMEVOQ Traitement Compassionnel
BRIEF published on 09/29/2025 at 23:05, 2 months 15 days ago GenSight Biologics Announces First Half 2025 Financial Results Financial Results Research And Development Treasury GenSight Biologics Early Access Programs
BRIEF published on 09/29/2025 at 23:05, 2 months 15 days ago GenSight Biologics annonce ses résultats financiers du premier semestre 2025 Résultats Financiers Recherche Et Développement Trésorerie GenSight Biologics Programmes D'accès Précoce
PRESS RELEASE published on 09/29/2025 at 23:00, 2 months 15 days ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie résultats financiers du premier semestre 2025 : gestion optimisée de trésorerie, financement post-clôture, transfert de fabrication, protocole d'étude soumis à l'ANSM Résultats Financiers Financement Trésorerie GenSight Biologics Étude ANSM
PRESS RELEASE published on 09/29/2025 at 23:00, 2 months 15 days ago Inside Information / News release on accounts, results GenSight Biologics reports 8.3% reduction in operating cash outflow and extends cash runway to late Q4 2025. Company's financial results show decrease in operating income, R&D expenses, and net cash flows Financial Results Operating Income Cash Management GenSight Biologics R&D Expenses
Published on 12/15/2025 at 09:01, 1 hour 43 minutes ago Apex Discovers Mineralized Carbonatite at its Lac Le Moyne Project, Québec
Published on 12/14/2025 at 23:00, 11 hours 44 minutes ago Fortescue to Acquire Alta Copper for C$1.40 per Share
Published on 12/13/2025 at 02:00, 2 days 8 hours ago Battery X Metals Announces Confidential Submission of Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 12/13/2025 at 00:13, 2 days 10 hours ago Prospect Ridge Announces Non-Brokered Private Placement
Published on 12/12/2025 at 23:05, 2 days 11 hours ago ReelTime's RLTR Stock Surges Past AI Giants Following LG Smart TV Debut of Reel Intelligence
Published on 12/15/2025 at 10:30, 14 minutes ago EQS-Adhoc: Gothaer Allgemeine Versicherung AG: BarmeniaGothaer closes its first financial year 2025 with a very good result
Published on 12/15/2025 at 10:15, 29 minutes ago Now Is Yours: Huawei Rolls Out Mate X7 Alongside a New Lineup of Innovative Products
Published on 12/15/2025 at 10:09, 35 minutes ago FAVEOS SE concludes strategic framework agreements with leading battery optimizers enspired and Entrix
Published on 12/15/2025 at 10:05, 39 minutes ago Voltage Energy Secures Industry's First Full-System 2kV EBOS Certification from UL Solutions
Published on 12/12/2025 at 18:00, 2 days 16 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 18:00, 2 days 16 hours ago Déclaration des transactions sur actions propres réalisées du 24 novembre au 28 novembre 2025
